Literature DB >> 19338607

Optical coherence tomography of the retina and optic nerve - a review.

Lisandro M Sakata1, Julio Deleon-Ortega, Viviane Sakata, Christopher A Girkin.   

Abstract

Optical coherence tomography (OCT) is a rapid non-contact method that allows in vivo imaging of the retina, optic nerve head and retinal nerve fibre layer (RNFL). Since its introduction in Ophthalmology approximately a decade ago, the use of this technology has disseminated into the clinical practice. OCT has proven to be a useful ancillary tool for assessing retinal diseases because of its capability to provide cross-sectional images of the retina, and also to perform quantitative analysis of retinal morphology. In glaucoma, the OCT represents one of the methods capable of documenting and analysing optic disc and RNFL morphology in attempt to diagnose and monitor glaucomatous optic neuropathy. Recently, the spectral domain OCT became available, a new technique that allowed major improvements particularly regarding image acquisition speed and image resolution. Future studies will address how these major technological advances will impact the use of the OCT in research and clinical practice.

Entities:  

Mesh:

Year:  2009        PMID: 19338607     DOI: 10.1111/j.1442-9071.2009.02015.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  68 in total

Review 1.  Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration.

Authors:  Kristin M Galetta; Peter A Calabresi; Elliot M Frohman; Laura J Balcer
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

2.  Optical coherence tomography measurements with the LENTIS Mplus multifocal intraocular lens.

Authors:  Eirini Skiadaresi; Colm McAlinden; Giuseppe Ravalico; Jonathan Moore
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-01-04       Impact factor: 3.117

3.  Retinal vessel optical coherence tomography images for anemia screening.

Authors:  Zailiang Chen; Yufang Mo; Pingbo Ouyang; Hailan Shen; Dabao Li; Rongchang Zhao
Journal:  Med Biol Eng Comput       Date:  2018-12-01       Impact factor: 2.602

4.  Assessment of OCT measurements as prognostic factors in myopic macular hole surgery without foveoschisis.

Authors:  Micol Alkabes; Leyla Padilla; Cecilia Salinas; Paolo Nucci; Lucia Vitale; Francesco Pichi; Anniken Burès-Jelstrup; Carlos Mateo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-05-22       Impact factor: 3.117

5.  Reproducibility and repeatability of optical coherence tomography imaging of the optic nerve head in normal beagle eyes.

Authors:  Alexandra M Bemis; Christopher G Pirie; Alexander J LoPinto; Louise Maranda
Journal:  Vet Ophthalmol       Date:  2017-02-01       Impact factor: 1.644

6.  Drusen analysis in a human-machine synergistic framework.

Authors:  R Theodore Smith; Mahsa A Sohrab; Nicole M Pumariega; Kanika Mathur; Raymond Haans; Anna Blonska; Karl Uy; Dominiek Despriet; Caroline Klaver
Journal:  Arch Ophthalmol       Date:  2011-01

7.  Optically buffered Jones-matrix-based multifunctional optical coherence tomography with polarization mode dispersion correction.

Authors:  Young-Joo Hong; Shuichi Makita; Satoshi Sugiyama; Yoshiaki Yasuno
Journal:  Biomed Opt Express       Date:  2014-12-18       Impact factor: 3.732

8.  Application of electrophysiological tests in the evaluation of early thyroid-associated ophthalmopathy.

Authors:  Yanjie Tian; Yuexin Wang; Jiahui Ma; Xuemin Li
Journal:  Doc Ophthalmol       Date:  2021-01-28       Impact factor: 2.379

Review 9.  Optical coherence tomography based angiography [Invited].

Authors:  Chieh-Li Chen; Ruikang K Wang
Journal:  Biomed Opt Express       Date:  2017-01-24       Impact factor: 3.732

10.  Real-time three-dimensional Fourier-domain optical coherence tomography video image guided microsurgeries.

Authors:  Jin U Kang; Yong Huang; Kang Zhang; Zuhaib Ibrahim; Jaepyeong Cha; W P Andrew Lee; Gerald Brandacher; Peter L Gehlbach
Journal:  J Biomed Opt       Date:  2012-08       Impact factor: 3.170

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.